Efficient Computer signed agreements for more than $97M at a $650M valuation to move a validated edge architecture into the data centre. Electron E1 runs on 1,000+ physical AI robots at up to 1 TOPS per watt. The data centre chip has no name and no tape-out date.
Kither Biotech started dosing COPD patients with KIT2014, a 42-amino-acid inhaled peptide that blocks PDE3 and PDE4 and, on the available evidence, does not leave the lung. The pathway Merck paid $10 billion for is de-risked. Getting a different molecule to stay put in the airway is not.
Energy Vault acquired Goshe Energy Storage's portfolio of 2.3+ GW across 15 US battery projects. Two, totalling 350 MW, are ready to build for Q1 2028 and roughly $30M of annual run-rate EBITDA. The scarce input in US storage is the queue position, not the megawatt.
A single-arm Phase 2 gave 53 patients PDS0101 plus pembrolizumab and reported 39.3-month median overall survival in JAMA Oncology. Five weeks earlier the company had terminated the confirmatory Phase 3 at 12 patients, citing financial constraints alone.
Two astronauts spent 286 days on the ISS because of a helium leak and thrusters that underperformed. On Monday NASA put that capsule back on a flight manifest. The fixes, though, arrive after the next flight rather than before it.
Token prices fell roughly 600-fold since June 2020 and enterprise cost per workload dropped 67% year over year, yet inference spend is still forecast to triple to $885B by 2030. Four delivery models now compete for the same workload: hyperscaler cloud, neocloud, neutral exchange, on-premises.
AnaCardio closed a €62.5M Series B co-led by Novo Holdings to move AC01 toward Phase 3. A 58-patient Lancet study showed a clean safety signal and better cardiac output — not yet the outcomes that decide whether a heart drug works.
Feather Robotics raised $7.6M in pre-seed led by Gradient Ventures and opened orders for a $29,990 wheeled humanoid developer platform — roughly one-third the price of rival research machines. It has booked more than $1M selling to kitchens and labs, and bets the body, not the model, is scarce.